<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>House Church Network | Lindgreen Lauritzen | Activity</title>
	<link>http://city-refuge.org/housechurch/members/pyjamatile1/activity/</link>
	<atom:link href="http://city-refuge.org/housechurch/members/pyjamatile1/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Lindgreen Lauritzen.</description>
	<lastBuildDate>Tue, 16 Dec 2025 20:45:54 +0000</lastBuildDate>
	<generator>https://buddypress.org/?v=</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">cce30cc635a7c6e5873df9ee9dba39da</guid>
				<title>Lindgreen Lauritzen posted an update: The imaging applied sciences also are necessary as new [&#133;]</title>
				<link>http://city-refuge.org/housechurch/activity/p/17288/</link>
				<pubDate>Thu, 02 Nov 2023 05:34:58 +0000</pubDate>

									<content:encoded><![CDATA[<p>The imaging applied sciences also are necessary as new remedies are developed for Alzheimer&#8217;s disease. The five Alzheimer&#8217;s phases might help you understand what might occur. But it&#8217;s essential to know that these levels are only rough generalizations.</p>
<div>
</div>
<p>Feelings of guilt may be troublesome to deal with as a carer of anyone&hellip;<span class="activity-read-more" id="activity-read-more-17288"><a href="http://city-refuge.org/housechurch/activity/p/17288/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">5b6387f10327b8c64abac973cc07660b</guid>
				<title>Lindgreen Lauritzen posted an update: Flortaucipir F18 (Tauvid®) has been accredited for detection [&#133;]</title>
				<link>http://city-refuge.org/housechurch/activity/p/16512/</link>
				<pubDate>Wed, 01 Nov 2023 23:24:35 +0000</pubDate>

									<content:encoded><![CDATA[<p>Flortaucipir F18 (Tauvid®) has been accredited for detection of tau in the mind. Florbetaben (Neuraceq®), Florbetapir (Amyvid®) and Flutemetamol (Vizamyl®) have been accredited for detection of beta-amyloid in the brain. Before a biomarker can be utilized in medical clinics, it should be validated, in which multiple research in giant and var&hellip;<span class="activity-read-more" id="activity-read-more-16512"><a href="http://city-refuge.org/housechurch/activity/p/16512/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">0325bb203d1a9e6f38474f2c4477fc16</guid>
				<title>Lindgreen Lauritzen posted an update: At the annual Clinical Trials on Alzheimer’s Disease c [&#133;]</title>
				<link>http://city-refuge.org/housechurch/activity/p/16511/</link>
				<pubDate>Wed, 01 Nov 2023 23:24:18 +0000</pubDate>

									<content:encoded><![CDATA[<p>At the annual Clinical Trials on Alzheimer’s Disease convention in Boston, Eisai and Biogen, makers of essentially the most just lately permitted drug, lecanemab , as well as Eli Lilly, maker of donanemab, which the us Food and Drug Administration is currently reviewing for possible approval by the end of the year, reported on their latest r&hellip;<span class="activity-read-more" id="activity-read-more-16511"><a href="http://city-refuge.org/housechurch/activity/p/16511/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">b15c68c0e9414d82ea3c590798cdfeed</guid>
				<title>Lindgreen Lauritzen posted an update: At the annual Clinical Trials on Alzheimer’s Disease c [&#133;]</title>
				<link>http://city-refuge.org/housechurch/activity/p/16509/</link>
				<pubDate>Wed, 01 Nov 2023 23:20:12 +0000</pubDate>

									<content:encoded><![CDATA[<p>At the annual Clinical Trials on Alzheimer’s Disease convention in Boston, Eisai and Biogen, makers of essentially the most lately accredited drug, lecanemab , as nicely as Eli Lilly, maker of donanemab, which the U.S. Food and Drug Administration is currently reviewing for potential approval by the end of the yr, reported on their latest s&hellip;<span class="activity-read-more" id="activity-read-more-16509"><a href="http://city-refuge.org/housechurch/activity/p/16509/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">5f3b307a7ed09d4c354f1f033002287f</guid>
				<title>Lindgreen Lauritzen became a registered member</title>
				<link>http://city-refuge.org/housechurch/activity/p/16492/</link>
				<pubDate>Wed, 01 Nov 2023 23:08:13 +0000</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>